Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0773
D

Failure to Complete Ordered HbA1c Lab Monitoring for a Resident

Glennville, Georgia Survey Completed on 04-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to follow physician orders for laboratory monitoring for a resident with a primary diagnosis of hemiplegia and hemiparesis following a nontraumatic intracerebral hemorrhage. The resident had an order for HbA1c testing to be performed quarterly in January, April, July, and October. Record review showed that the last HbA1c was drawn in March 2024, with no evidence of the test being completed in October 2024 or January 2025 as ordered. Pharmacy progress notes in November 2024 and February 2025 recommended updating HbA1c lab monitoring, but there was no documentation that these recommendations were acted upon. Interviews with the DON and Corporate Compliance Nurse confirmed that the expected process was for labs to be drawn as ordered and for recommendations from pharmacy reviews to be communicated to the physician or nurse practitioner. However, the facility did not have a protocol or policy in place to ensure laboratory monitoring was completed, and the resident was not included on the lab draw lists generated by Clinical Laboratory Services for the relevant months. The facility was unable to provide proof that the required HbA1c tests were performed as ordered.

An unhandled error has occurred. Reload 🗙